Nomenclature: Coronavirus and the 2019 Novel Coronavirus

Hu Zhi, Zhongliang Yang, Qi Li, Yongfeng HuangPreprints.org 2020 · DOI

Abstract

Less aligned emphasis has been given to naming the 2019 novel coronavirus and pandemic disease. Global profusion of squab names has found their ways in daily communication, and our survey promises to articulate that many of them may have contributed to backlash against Chinese people. Here, based on brief critical reviews on the naming of coronavirus and human coronaviruses, we scrutinize a clear sense of pros and cons of previous multifarious names and punctuate heuristic introspection of naming practices. Our findings suggest that full-fledged official names are duly contribute to the resilience of healthy collective usages in current infodemic scenario.
BibTeX
@misc{zhi2020nomenclature,
  author = {Hu Zhi and Zhongliang Yang and Qi Li and Yongfeng Huang},
  title = {{Nomenclature: Coronavirus and the 2019 Novel Coronavirus}},
  year = {2020},
  doi = {10.20944/preprints202002.0380.v1},
  howpublished = {Preprints.org},
}

Loading related content...

Figure